Skip to main content
Clinical Trials/DRKS00019834
DRKS00019834
Completed
Not Applicable

CSF-analysis in SMA - searching biomarkers in CSF of patients with spinal muscular atrophy via proteomic analysis and neurofilament-ELISA - SMA-CSF

niversitätsklinikum Freiburg0 sites31 target enrollmentApril 5, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
G12.1
Sponsor
niversitätsklinikum Freiburg
Enrollment
31
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 5, 2022
End Date
March 22, 2022
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Genetically proven 5q spinal muscular atrophy of all subtypes
  • Collection of CSF as part of a medically indicated lumbar puncture (e.g. intrathecal therapy with Nusinersen)
  • Written declaration of consent from the legal guardians for the scientific use of data and samples from the corresponding biobanks
  • Written declaration of consent from the patient to the scientific use of data and samples from the corresponding biobanks, provided that he is able to understand the nature, significance and scope of the study in terms of age and stage of development and to determine his will accordingly.

Exclusion Criteria

  • Known intracranial or intraspinal malignancy

Outcomes

Primary Outcomes

Not specified

Similar Trials